iSpecimen to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022
May 16 2022 - 7:30AM
iSpecimen Inc.
(Nasdaq: ISPC) (“iSpecimen” or the “Company”), an
online global marketplace that connects scientists in need of
biospecimens for medical research with a network of healthcare
specimen providers, today announced that Christopher Ianelli, MD,
PhD, CEO and President of iSpecimen, will participate virtually in
the H.C. Wainwright Global Investment Conference to be held on May
23-26, 2022.
Dr. Ianelli's corporate presentation will be available on-demand
starting Tuesday, May 24, 2022 at 7:00 a.m. ET for all registrants
of the virtual conference. To attend, please register here.For more
information about the conference, or to schedule a one-on-one
meeting with iSpecimen’s management team, please contact your
appropriate H.C. Wainwright representative, or send an email to
KCSA Strategic Communications at iSpecimen@kcsa.com.
About iSpecimen
iSpecimen (Nasdaq: ISPC) offers an online marketplace for human
biospecimens, connecting scientists in commercial and non-profit
organizations with healthcare providers that have access to
patients and specimens needed for medical discovery. Proprietary,
cloud-based technology enables scientists to intuitively search for
specimens and patients across a federated partner network of
hospitals, labs, biobanks, blood centers and other healthcare
organizations. For more information, please visit
www.ispecimen.com.
For further information, please contact:
Investor ContactKCSA Strategic
CommunicationsAllison SossiSpecimen@kcsa.com
Media ContactsKCSA Strategic
CommunicationsRaquel Cona / Shana MarinoiSpecimen@kcsa.com
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Aug 2024 to Sep 2024
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Sep 2023 to Sep 2024